Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
2.175
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Shanghai Fosun Pharmaceutical EPS Diluted (Quarterly) : 0.0476 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0476 |
| December 31, 2025 | 0.0453 |
| September 30, 2025 | 0.0435 |
| June 30, 2025 | 0.0491 |
| March 31, 2025 | 0.0396 |
| December 31, 2024 | 0.0397 |
| September 30, 2024 | 0.0412 |
| June 30, 2024 | 0.0318 |
| March 31, 2024 | 0.0318 |
| December 31, 2023 | 0.0053 |
| September 30, 2023 | 0.0254 |
| June 30, 2023 | 0.0422 |
| March 31, 2023 | 0.054 |
| December 31, 2022 | 0.0672 |
| September 30, 2022 | 0.0496 |
| June 30, 2022 | 0.0638 |
| March 31, 2022 | 0.0281 |
| December 31, 2021 | 0.0714 |
| September 30, 2021 | 0.0653 |
| June 30, 2021 | 0.0988 |
| March 31, 2021 | 0.051 |
| December 31, 2020 | 0.0697 |
| September 30, 2020 | 0.0431 |
| June 30, 2020 | 0.0626 |
| March 31, 2020 | 0.0323 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0697 |
| September 30, 2019 | 0.0305 |
| June 30, 2019 | 0.046 |
| March 31, 2019 | 0.0412 |
| December 31, 2018 | 0.0346 |
| September 30, 2018 | 0.0306 |
| June 30, 2018 | 0.0537 |
| March 31, 2018 | 0.044 |
| December 31, 2017 | 0.0423 |
| September 30, 2017 | 0.0435 |
| June 30, 2017 | 0.0556 |
| March 31, 2017 | 0.0444 |
| December 31, 2016 | 0.0385 |
| September 30, 2016 | 0.0439 |
| June 30, 2016 | 0.0572 |
| March 31, 2016 | 0.042 |
| December 31, 2015 | 0.0385 |
| September 30, 2015 | 0.0403 |
| June 30, 2015 | 0.0535 |
| March 31, 2015 | 0.0372 |
| December 31, 2014 | 0.0379 |
| September 30, 2014 | 0.0391 |
| June 30, 2014 | 0.042 |
| March 31, 2014 | 0.0304 |
| December 31, 2013 | 0.0463 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 155.92M |
| Revenue (Quarterly) | 1.455B |
| Total Expenses (Quarterly) | 1.329B |
| Enterprise Value | 11.41B |
| Gross Profit Margin (Quarterly) | 49.70% |
| Profit Margin (Quarterly) | 10.72% |
| Earnings Yield | 8.53% |
| Operating Earnings Yield | 6.56% |
| Normalized Earnings Yield | 8.317 |